NPI: 1003861188 · SAINT FRANCIS, WI 53235 · Clinic/Center · NPI assigned 05/24/2006
Authorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
| Authorized Official | RICHARDSON, KARA (ASSISTANT TREASURER) |
| NPI Enumeration Date | 05/24/2006 |
Other providers sharing the same authorized official: RICHARDSON, KARA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 40,170 | $1.09M |
| 2019 | 42,094 | $1.06M |
| 2020 | 32,138 | $800K |
| 2021 | 49,541 | $1.11M |
| 2022 | 61,645 | $1.48M |
| 2023 | 59,820 | $1.42M |
| 2024 | 41,787 | $1.42M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 77,982 | 71,632 | $3.06M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 69,626 | 64,481 | $1.94M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5,145 | 4,665 | $304K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4,150 | 4,052 | $245K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 12,577 | 4,420 | $231K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 16,088 | 6,715 | $220K |
| 99215 | Prolong outpt/office vis | 3,170 | 2,939 | $179K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4,506 | 4,297 | $142K |
| 99233 | Prolong inpt eval add15 m | 5,534 | 2,527 | $129K |
| 99223 | Prolong inpt eval add15 m | 3,037 | 2,768 | $124K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2,044 | 1,995 | $119K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2,374 | 2,157 | $117K |
| 99000 | 31,406 | 28,929 | $117K | |
| 90686 | 9,489 | 9,257 | $97K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3,920 | 1,796 | $89K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2,012 | 1,867 | $86K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,656 | 1,593 | $79K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 898 | 847 | $62K |
| 99222 | Initial hospital care, per day, moderate complexity | 1,725 | 1,598 | $59K |
| 11721 | 5,115 | 4,818 | $56K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 584 | 573 | $55K |
| 0240U | 1,625 | 1,519 | $52K | |
| 3008F | 5,226 | 4,975 | $46K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1,001 | 448 | $46K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 367 | 341 | $45K |
| 91322 | 371 | 312 | $39K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,102 | 895 | $29K |
| 90677 | 516 | 503 | $25K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 406 | 397 | $23K |
| 20610 | 518 | 482 | $23K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,152 | 490 | $22K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 670 | 638 | $21K |
| 99243 | 310 | 296 | $18K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 201 | 195 | $18K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 747 | 695 | $17K |
| 0124A | 480 | 473 | $16K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2,449 | 2,292 | $16K |
| 91321 | 217 | 128 | $15K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 582 | 563 | $14K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 540 | 493 | $14K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 378 | 355 | $14K |
| 90480 | 488 | 405 | $14K | |
| 80053 | Comprehensive metabolic panel | 1,538 | 1,446 | $13K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 810 | 772 | $12K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 453 | 442 | $12K |
| 87210 | 2,165 | 2,028 | $11K | |
| 90670 | 2,413 | 2,362 | $11K | |
| 99254 | 189 | 171 | $11K | |
| 11720 | 1,538 | 1,479 | $11K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 424 | 401 | $10K |
| 99442 | 627 | 491 | $10K | |
| 90723 | 1,399 | 1,366 | $10K | |
| 90647 | 1,150 | 1,118 | $9K | |
| 99253 | 169 | 162 | $9K | |
| 71046 | Radiologic examination, chest; 2 views | 435 | 425 | $8K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 258 | 152 | $8K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 78 | 67 | $8K |
| 90656 | 380 | 374 | $7K | |
| 92567 | 434 | 410 | $7K | |
| 0134A | 191 | 189 | $6K | |
| 0064A | 193 | 174 | $6K | |
| 93015 | 138 | 124 | $6K | |
| 98926 | 255 | 225 | $6K | |
| 96127 | 970 | 897 | $5K | |
| 90680 | 627 | 613 | $5K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 92 | 89 | $5K |
| 90688 | 323 | 309 | $5K | |
| 0054A | 150 | 146 | $5K | |
| 90672 | 277 | 267 | $5K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 66 | 54 | $5K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 711 | 619 | $5K |
| 90746 | 87 | 80 | $5K | |
| 0071A | 111 | 110 | $4K | |
| 92523 | 30 | 26 | $4K | |
| 95816 | 189 | 169 | $4K | |
| 82075 | 253 | 145 | $4K | |
| 95819 | 172 | 156 | $4K | |
| 85610 | 1,159 | 772 | $4K | |
| 0051A | 108 | 105 | $4K | |
| 0072A | 86 | 85 | $3K | |
| 0111A | 112 | 101 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 224 | 106 | $3K |
| 98940 | 209 | 78 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 127 | 113 | $3K |
| 51701 | 95 | 94 | $3K | |
| 90633 | 448 | 434 | $3K | |
| 76642 | 52 | 43 | $3K | |
| J2785 | Injection, regadenoson, 0.1 mg | 51 | 37 | $3K |
| 36415 | Collection of venous blood by venipuncture | 6,529 | 5,857 | $2K |
| 81001 | 1,014 | 952 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 370 | 350 | $2K |
| 36416 | 960 | 714 | $2K | |
| 0001A | 56 | 56 | $2K | |
| 0002A | 54 | 53 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 280 | 267 | $2K |
| 90739 | 16 | 12 | $2K | |
| 0112A | 48 | 46 | $1K | |
| 0004A | 38 | 38 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 138 | 130 | $1K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 154 | 84 | $1K |
| 99383 | 24 | 24 | $1K | |
| 90660 | 85 | 84 | $1K | |
| 0154A | 32 | 31 | $1K | |
| 99220 | 29 | 28 | $1K | |
| 99152 | 29 | 27 | $950.33 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 16 | 14 | $875.49 |
| 90651 | 161 | 161 | $830.23 | |
| 99306 | Prolong nursin fac eval 15m | 32 | 27 | $807.11 |
| 97162 | 13 | 12 | $753.32 | |
| 99385 | 13 | 13 | $741.52 | |
| 81025 | 86 | 86 | $738.69 | |
| 90685 | 222 | 215 | $731.43 | |
| 69210 | 65 | 56 | $698.19 | |
| 99441 | 83 | 61 | $691.90 | |
| 99443 | 30 | 22 | $656.59 | |
| 80061 | Lipid panel | 68 | 58 | $656.23 |
| 83037 | 100 | 95 | $592.42 | |
| 99421 | 57 | 45 | $577.09 | |
| 93793 | 108 | 77 | $475.27 | |
| 0121A | 14 | 12 | $462.87 | |
| 90715 | 28 | 28 | $461.93 | |
| 92579 | 18 | 16 | $444.76 | |
| 99225 | 21 | 17 | $427.92 | |
| 0053A | 13 | 12 | $423.95 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 79 | 75 | $423.04 |
| 80050 | General health panel | 13 | 12 | $411.29 |
| 99226 | 16 | 13 | $410.85 | |
| 90710 | 65 | 65 | $354.99 | |
| 81003 | 224 | 204 | $320.93 | |
| 81002 | 118 | 110 | $301.47 | |
| 96380 | 13 | 12 | $300.60 | |
| 82962 | 123 | 115 | $284.38 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 10,053 | 3,489 | $280.12 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 12 | 12 | $276.68 |
| 98942 | 43 | 12 | $224.77 | |
| 92552 | 12 | 12 | $200.52 | |
| 84443 | Thyroid stimulating hormone (TSH) | 24 | 24 | $197.43 |
| 90662 | 14 | 12 | $173.64 | |
| 90734 | 54 | 52 | $173.37 | |
| 87081 | 36 | 33 | $146.65 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 12 | 12 | $142.50 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 12 | 12 | $105.56 |
| 99221 | 75 | 70 | $93.50 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 75 | 73 | $89.44 |
| 90681 | 27 | 25 | $83.80 | |
| 51798 | 15 | 14 | $80.71 | |
| 85027 | 12 | 12 | $74.15 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 12 | 12 | $1.46 |
| 97014 | 565 | 302 | $0.00 | |
| 91305 | 17 | 17 | $0.00 | |
| 91313 | 29 | 28 | $0.00 | |
| 91312 | 91 | 88 | $0.00 |